Vielight Starts Clinical Trial to Study Photobiomodulation Device Treatment for Post-Covid Cognitive Impairment
July 26, 2023 10:33 ET
|
Vielight Inc.
Toronto, Canada, July 26, 2023 (GLOBE NEWSWIRE) -- Vielight Inc. announced it has commenced a new clinical trial in the United States to study how brain stimulation photobiomodulation (PBM)...
Vielight Founder, Dr. Lew Lim Granted a Patent for Artificial Intelligence (AI) Brain Stimulation & Assigns to Vielight Inc.
July 13, 2023 15:58 ET
|
Vielight Inc.
Toronto, Canada, July 13, 2023 (GLOBE NEWSWIRE) -- The United States Patent and Trademark Office (USPTO) on April 25, 2023, granted a utility patent to Dr. Lew Lim for his invention, “System and...
Vielight Inc. Receives Health Canada Approval for Treatment of Covid-19 with Near Infrared Device Technology
June 14, 2023 16:13 ET
|
Vielight Inc.
Toronto, Canada, June 14, 2023 (GLOBE NEWSWIRE) -- Update to Release on Globe Newswire from May 25, 2023 13:30 ET Vielight announced on Thursday, May 25, 2023 that its Vielight RX Plus device -...
Vielight pushes photobiomodulation research to a new level.
March 29, 2022 08:00 ET
|
Vielight Inc.
Toronto, Canada, March 29, 2022 (GLOBE NEWSWIRE) -- Vielight Inc., a global leader in transcranial photobiomodulation (tPBM) research, development and manufacturing, is pleased to announce a new...
Vielight pushes photobiomodulation research to a new level.
March 29, 2022 08:00 ET
|
Vielight Inc.
Toronto, Canada, March 29, 2022 (GLOBE NEWSWIRE) -- Vielight Inc., a global leader in transcranial photobiomodulation (tPBM) research, development and manufacturing, is pleased to announce a new...
Vielight Commences Recruitment for COVID-19 Clinical Trial in Ontario
September 10, 2020 09:00 ET
|
Vielight Inc.
Toronto, Canada, Sept. 10, 2020 (GLOBE NEWSWIRE) -- Vielight Inc. is pleased to announce the commencement of recruitment for a COVID-19 clinical trial in Ontario, Canada. This involves a home-use...
Vielight Launches COVID-19 Clinical Trial with Home-Use Device
September 01, 2020 09:00 ET
|
Vielight Inc.
Toronto, Canada, Sept. 01, 2020 (GLOBE NEWSWIRE) -- Vielight Inc. is pleased to announce the commencement of a new clinical trial in the USA. In this trial, Vielight Inc. will test the hypothesis...
Vielight Commences Pivotal Clinical Trial for Alzheimer’s Disease based on Transcranial Photobiomodulation.
June 04, 2019 06:00 ET
|
Vielight Inc.
Toronto, Canada, June 04, 2019 (GLOBE NEWSWIRE) -- Vielight Inc. of Toronto, a leader in brain photobiomodulation (PBM) technology, announces that the primary site for its pivotal clinical trial,...